| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |